Ionis

Pharma

FDA approves transformational expansion of Ionis’ Tryngolza

Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.

Kevin Dunleavy Jun 25, 2026 8:13am

Space shuttle takes off on background of blue sky

As questions swirl, Alnylam eyes ATTR market leadership by 2030

Mar 26, 2026 2:08pm

JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26

Jan 13, 2026 7:29pm

Ionis doubles its sales projection for Tryngolza in sHTG to $2B

Jan 13, 2026 3:45pm

Arrowhead strikes true with first FDA approval

Nov 18, 2025 3:44pm

Ionis' Tryngolza win in sHTG sends shares soaring by 27%

Sep 2, 2025 11:30am